Inner ear gene transfection in neonatal mice using adeno-associated viral vector: a comparison of two approaches.

Published on Aug 17, 2012in PLOS ONE2.74
· DOI :10.1371/JOURNAL.PONE.0043218
Li Xia8
Estimated H-index: 8
(SJTU: Shanghai Jiao Tong University),
Shankai Yin25
Estimated H-index: 25
(SJTU: Shanghai Jiao Tong University),
Jian Wang59
Estimated H-index: 59
(Dal: Dalhousie University)
Local gene transfection is a promising technique for the prevention and/or correction of inner ear diseases, particularly those resulting from genetic defects. Adeno-associated virus (AAV) is an ideal viral vector for inner ear gene transfection because of its safety, stability, long-lasting expression, and its high tropism for many different cell types. Recently, a new generation of AAV vectors with a tyrosine mutation (mut-AAV) has demonstrated significant improvement in transfection efficiency. A method for inner ear gene transfection via the intact round window membrane (RWM) has been developed in our laboratory. This method has not been tested in neonatal mice, an important species for the study of inherited hearing loss. Following a preliminary study to optimize the experimental protocol in order to reduce mortality, the present study investigated inner ear gene transfection in mice at postnatal day 7. We compared transfection efficiency, the safety of the scala tympani injection via RWM puncture, and the trans-RWM diffusion following partial digestion with an enzyme technique. The results revealed that approximately 47% of inner hair cells (IHCs) and 17% of outer hair cells (OHCs) were transfected via the trans-RWM approach. Transfection efficiency via RWM puncture (58% and 19% for IHCs and OHCs, respectively) was slightly higher, but the difference was not significant.
📖 Papers frequently viewed together
8 Authors (Omar Akil, ..., Lawrence R. Lustig)
232 Citations
72 Citations
148 Citations
#1Huiping Wang (SJTU: Shanghai Jiao Tong University)H-Index: 7
#2R Murphy (Dal: Dalhousie University)H-Index: 1
Last. Jian Wang (Dal: Dalhousie University)H-Index: 59
view all 9 authors...
The auditory portion of the inner ear, the cochlea, is an ideal organ for local gene transfection owing to its relative isolation. Various carriers have been tested for cochlear gene transfection. To date, viral vectors appear to have much higher transfection efficacy than non-viral mechanisms. Among these vectors, recombinant adeno-associated virus (rAAV) vectors have several advantages such as being non-pathogenic and the ability to produce prolonged gene expression in various cell types. Howe...
37 CitationsSource
#1Lauren A. Kilpatrick (MUSC: Medical University of South Carolina)H-Index: 7
#2Qian Li (MUSC: Medical University of South Carolina)H-Index: 1
Last. Hainan Lang (MUSC: Medical University of South Carolina)H-Index: 21
view all 6 authors...
Murine models are ideal for studying cochlear gene transfer, as many hearing loss-related mutations have been discovered and mapped within the mouse genome. However, because of the small size and delicate nature, the membranous labyrinth of the mouse is a challenging target for the delivery of viral vectors. To minimize injection trauma, we developed a procedure for the controlled release of adeno-associated viruses (AAVs) into the scala media of adult mice. This procedure poses minimal risk of ...
72 CitationsSource
#1Guy P. Richardson (University of Sussex)H-Index: 68
#2Jacques Boutet de Monvel (Pasteur Institute)H-Index: 19
Last. Christine Petit (Pasteur Institute)H-Index: 75
view all 3 authors...
Although the basic principles underlying the function of the peripheral auditory system have been known for many years, the molecules required for hearing have hitherto remained elusive. Genetic approaches have recently provided unparalleled molecular insight into how the hair bundle, the hair cell's mechanosensory organelle, forms and functions. We discuss how the proteins encoded by the Usher syndrome type 1 genes form molecular complexes required for hair-bundle development and for gating the...
160 CitationsSource
#1Ping Lv (UC Davis: University of California, Davis)H-Index: 7
#2Dongguang Wei (UC Davis: University of California, Davis)H-Index: 11
Last. Ebenezer N. YamoahH-Index: 28
view all 3 authors...
Abstract Alterations in Kv7-mediated currents in excitable cells result in several diseased conditions. A case in DFNA2, an autosomal dominant version of progressive hearing loss, involves degeneration of hair cells and spiral ganglion neurons (SGNs) from basal to apical cochlea, manifesting as high-to-low frequency hearing loss, and has been ascribed to mutations in Kv7.4 channels. Analyses of the cellular mechanisms of Kv7.4 mutations and progressive degeneration of SGNs have been hampered by ...
45 CitationsSource
#1Amiel A. Dror (TAU: Tel Aviv University)H-Index: 15
#2Karen B. Avraham (TAU: Tel Aviv University)H-Index: 56
Hearing loss (HL), or deafness in its most severe form, affects an estimated 28 and 22.5 million Americans and Europeans, respectively. The numbers are higher in regions such as India and the Middle East, where consanguinity contributes to larger numbers of recessively inherited hearing impairment (HI). As a result of work-related difficulties, educational and developmental delays, and social stigmas and exclusion, the economic impact of HL is very high. At the other end of the spectrum, a rich ...
154 CitationsSource
#1Li ZhongH-Index: 34
#2Baozheng Li (UF: University of Florida)H-Index: 15
Last. Arun SrivastavaH-Index: 72
view all 12 authors...
Abstract We have documented that epidermal growth factor receptor protein tyrosine kinase (EGFR-PTK) signaling negatively affects intracellular trafficking and transduction efficiency of recombinant adeno-associated virus 2 (AAV2) vectors. Specifically, inhibition of EGFR-PTK signaling leads to decreased ubiquitination of AAV2 capsid proteins, which in turn, facilitates viral nuclear transport by limiting proteasome-mediated degradation of AAV2 vectors. In the present studies, we observed that A...
177 CitationsSource
Purpose of reviewMutations in GJB2 and GJB6, the genes encoding the gap-junction proteins Connexin 26 and connexin 30, are the most common cause of autosomal recessive nonsyndromic deafness in many populations across the world. In this review, we discuss current ideas about the roles of gap junctions in the inner ear and the implications of connexin mutations on auditory function.Recent findingsIn recent years, a complex picture of the roles of gap junctions in cochlear physiology emerged. Rathe...
85 CitationsSource
Recombinant adeno-associated virus 2 (AAV2) vectors are in use in several Phase I/II clinical trials, but relatively large vector doses are needed to achieve therapeutic benefits. Large vector doses also trigger an immune response as a significant fraction of the vectors fails to traffic efficiently to the nucleus and is targeted for degradation by the host cell proteasome machinery. We have reported that epidermal growth factor receptor protein tyrosine kinase (EGFR-PTK) signaling negatively af...
466 CitationsSource
#1Laura Pietola (HYKS: Helsinki University Central Hospital)H-Index: 5
#2Antti A. Aarnisalo (HYKS: Helsinki University Central Hospital)H-Index: 18
Last. Jussi Jero (HYKS: Helsinki University Central Hospital)H-Index: 24
view all 6 authors...
Conclusion. GFP transgene was expressed in the lining cells of the perilymphatic space. Lentivirus vectors are safe and cause only minimal inflammatory reaction. Transgene products can be delivered into the perilymph by utilizing lentivirus vectors. Objectives. To analyze the efficiency and safety of lentiviral vectors HOX-GFP and WOX-GFP in intracochlear gene transfer. Materials and methods. Lentivirus vectors were tested for their transduction efficiency in vivo in CD-1 mice. Half of the anima...
28 CitationsSource
#1Masaya Konishi (Kansai Medical University)H-Index: 8
#2Kohei Kawamoto (Kansai Medical University)H-Index: 18
Last. Toshio Yamashita (Kansai Medical University)H-Index: 26
view all 5 authors...
Background Several genes are candidates for treating inner ear diseases. For clinical applications, minimally invasive approaches to the inner ear are desirable along with minimal side-effects. Methods Adeno-associated virus (AAV) was used as a vector into the guinea pig inner ear. Six AAV-cytomegalovirus hybrids (AAV-2/1, -2/2, -2/5, -2/7, -2/8 and -2/9) were infused into perilymph of the cochlea basal turn, an approach that could be used in cochlear implant surgery. At 7 days after injection, ...
74 CitationsSource
Cited By28
#1Annamaria FranzèH-Index: 15
Last. Elio MarcianoH-Index: 19
view all 7 authors...
#1Sida Huang (CSU: Central South University)H-Index: 1
#2Jian Song (CSU: Central South University)H-Index: 4
Last. Yong Feng (University of South China)H-Index: 13
view all 7 authors...
Waardenburg syndrome (WS), also known as auditory-pigmentary syndrome, is the most common cause of syndromic hearing loss (HL), which accounts for approximately 2-5% of all patients with congenital hearing loss. WS is classified into four subtypes depending on the clinical phenotypes. Currently, pathogenic mutations of PAX3, MITF, SOX10, EDN3, EDNRB or SNAI2 are associated with different subtypes of WS. Although supportive techniques like hearing aids, cochlear implants, or other assistive liste...
1 CitationsSource
#1Ning Ding (Rice University)H-Index: 4
#2Sangsin Lee (Rice University)H-Index: 2
Last. Xue Gao (Rice University)H-Index: 18
view all 5 authors...
Abstract According to the World Health Organization, hearing loss affects over 466 million people worldwide and is the most common human sensory impairment. It is estimated that genetic factors contribute to the causation of approximately 50% of congenital hearing loss. Yet, curative approaches to reversing or preventing genetic hearing impairment are still limited. The clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR-Cas9) systems enable programmable and ta...
4 CitationsSource
#1Dorien Verdoodt (University of Antwerp)H-Index: 1
#2Noa Peeleman (University of Antwerp)H-Index: 1
Last. Peter Ponsaerts (University of Antwerp)H-Index: 35
view all 5 authors...
Background: Hearing impairment is the most frequent sensory deficit, affecting 466 million people worldwide and has been listed by the World Health Organization (WHO) as one of the priority diseases for research into therapeutic interventions to address public health needs. Inner ear gene therapy is a promising approach to restore sensorineural hearing loss, for which several gene therapy applications have been studied and reported in preclinical animal studies. Objective: To perform a systemati...
#1Graham R. Casey (UMMC: University of Mississippi Medical Center)H-Index: 1
#2Charles Askew (UNC: University of North Carolina at Chapel Hill)H-Index: 9
Last. Bradley J. Walters (UMMC: University of Mississippi Medical Center)
view all 7 authors...
Sensorineural hearing loss is one of the most common disabilities worldwide. Such prevalence necessitates effective tools for studying the molecular workings of cochlear cells. One prominent and effective vector for expressing genes of interest in research models is adeno-associated virus (AAV). However, AAV efficacy in transducing cochlear cells can vary for a number of reasons including serotype, species, and methodology, and oftentimes requires high multiplicity of infection which can damage ...
#1Zhen Zhang (SJTU: Shanghai Jiao Tong University)H-Index: 3
#2Jiping Wang (SJTU: Shanghai Jiao Tong University)H-Index: 5
Last. Feng Liu (SJTU: Shanghai Jiao Tong University)H-Index: 1
view all 6 authors...
Sensorineural hearing loss, the most common form of hearing impairment, is mainly attributable to genetic mutations or acquired factors, such as aging, noise exposure, and ototoxic drugs. In the field of gene therapy, advances in genetic and physiological studies and profound increases in knowledge regarding the underlying mechanisms have yielded great progress in terms of restoring the auditory function in animal models of deafness. Nonetheless, many challenges associated with the translation f...
3 CitationsSource
#1Patricia A. Leake (UCSF: University of California, San Francisco)H-Index: 34
#2Omar Akil (UCSF: University of California, San Francisco)H-Index: 16
Last. Hainan Lang (MUSC: Medical University of South Carolina)H-Index: 21
view all 3 authors...
Abstract Hearing impairment is a major health and economic concern worldwide. Currently the cochlear implant (CI) is the standard of care for remediation of severe to profound hearing loss, and in general, contemporary CIs are highly successful. But there is great variability in outcomes among individuals, especially in children, with many CI users deriving much less or even marginal benefit. Much of this variability is related to differences in auditory nerve survival, and there has been substa...
6 CitationsSource
#1Fabian Blanc (French Institute of Health and Medical Research)H-Index: 1
#2Michel Mondain (French Institute of Health and Medical Research)H-Index: 34
Last. Jing Wang (University of Montpellier)H-Index: 29
view all 6 authors...
Over the last decade, pioneering molecular gene therapy for inner-ear disorders have achieved experimental hearing improvements after a single local or systemic injection of adeno-associated, virus-derived vectors (rAAV for recombinant AAV) encoding an extra copy of a normal gene, or ribozymes used to modify a genome. These results hold promise for treating congenital or later-onset hearing loss resulting from monogenic disorders with gene therapy approaches in patients. In this review, we summa...
5 CitationsSource
#1Shahar Taiber (TAU: Tel Aviv University)H-Index: 5
#2Karen B. Avraham (TAU: Tel Aviv University)H-Index: 56
Abstract More than 15 years have passed since the official completion of the Human Genome Project. Predominantly due to this project, over one hundred genes have now been linked to hearing loss. Although major advancements have been made in the understanding of underlying pathologies in deafness as a consequence of these gene discoveries, biological treatments for these conditions are still not available and current treatments rely on amplification or prosthetics. A promising approach for develo...
9 CitationsSource
#1Ryotaro Omichi (Roy J. and Lucille A. Carver College of Medicine)H-Index: 5
#2Seiji B. Shibata (Roy J. and Lucille A. Carver College of Medicine)H-Index: 7
Last. Richard J.H. Smith (Roy J. and Lucille A. Carver College of Medicine)H-Index: 137
view all 4 authors...
: Sensorineural hearing loss (SNHL) is the most common sensory disorder. Its underlying etiologies include a broad spectrum of genetic and environmental factors that can lead to hearing loss that is congenital or late onset, stable or progressive, drug related, noise induced, age related, traumatic or post-infectious. Habilitation options typically focus on amplification using wearable or implantable devices; however exciting new gene-therapy-based strategies to restore and prevent SNHL are acti...
26 CitationsSource